Keyphrases
Ovarian Cancer
100%
Ovarian Cancer Biomarkers
100%
Cancer Biomarker Discovery
100%
Omics Technologies
100%
Biomarker Discovery
80%
Affinity-based
40%
United States
20%
Treatment Options
20%
Poor Prognosis
20%
Multiplexing
20%
Discovery Process
20%
Multiplex Assay
20%
Patient Treatment
20%
Diagnostic Biomarker
20%
Novel Diagnostics
20%
Ion Mobility Spectrometry
20%
Regulatory Approval
20%
Bona Fide
20%
Significant Benefit
20%
Novel Technique
20%
Expert Opinion
20%
Low Protein
20%
Mass Spectrometry Methods
20%
O-linked
20%
DNA Aptamer
20%
Assay Platform
20%
Area Cover
20%
Discovery pipeline
20%
Late-stage Diagnosis
20%
Proximity Extension Assay
20%
SomaLogic
20%
Early-stage Detection
20%
Novel Prognostic Biomarker
20%
Cancer Proteome
20%
Biochemistry, Genetics and Molecular Biology
Biomarker Discovery
100%
Tumor Marker
100%
Proteomics
100%
Proteome
20%
Mass Spectrometry
20%
Translating (Language)
20%
Aptamer
20%
Ion-Mobility Spectrometry
20%
Diagnostic Biomarker
20%